Mr. Chowdhury is the president of and an investment consultant at Canterbury, serves on the Board of Directors, and is a shareholder of the firm. In his role as president, Mr. Chowdhury is responsible for firm strategy, consulting, investment research, and business development. He consults directly to not-for-profit institutions in the key areas of investment policy, asset allocation, and portfolio construction. Mr. Chowdhury is a member of the ESG and Global Equity Research Committees. Prior to Canterbury, he was a contributor to the Human Genome Project while working in the Department of Pharmacology at the University of Minnesota. While there, he was lead author of a paper published in th